What is Vyome Holdings, Inc.?
, a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 8.42M, and a P/E ratio of 0.3x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.